2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Evans Syndrome: new trials by email Literature Review of Evans Syndrome trials Research Report on Evans Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia combination of a single dose anti-CD20 antibody and bortezomib - Autoimmune Hemolytic Anemia, Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia | Phase 2 | Completed | Peking Union Medical College Hospital | 33 | 2019-08-20 | 2024-04-26 |
| Sirolimus for Autoimmune Disease of Blood Cells sirolimus - Autoimmune Pancytopenia, Autoimmune Lymphoproliferative Syndrome (ALPS) | Phase 1 / Phase 2 | Completed | Children's Hospital of Philadelphia | 30 | 2006-12-01 | 2019-11-19 |
Anemia, Hemolytic, Autoimmune (2) · Anemia, Hemolytic (1) · Arthritis, Rheumatoid (1) · Autoimmune Lymphoproliferative Syndrome (1) · Cytopenia (1) · Inflammatory Bowel Diseases (1) · Lupus Erythematosus, Systemic (1) · Neutropenia (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Recurrence (1)
Anemia (2) · Autoimmune Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Agranulocytosis (1) · Anemia, Hemolytic (1) · Arthritis (1) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Digestive System Diseases (1)
Bortezomib (1) · Injections (1) · Rituximab (1) · Sirolimus (1)
Children's Hospital of Philadelphia (1) · Peking Union Medical College Hospital (1)
China (1) · United States (1)
Bing Han (1) · David T. Teachey, MD (1)